药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aluminium monostearate
Dexpropranolol
Dexibuprofen may decrease the antihypertensive activities of Dexpropranolol.
Aluminium monostearate
Cilazaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Cilazaprilat.
Aluminium monostearate
Quinoline Yellow WS
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Quinoline Yellow WS.
Aluminium monostearate
Quinaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Quinaprilat.
Aluminium monostearate
Perindoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Perindoprilat.
Aluminium monostearate
Moexiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Moexiprilat.
Aluminium monostearate
Trandolaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Trandolaprilat.
Aluminium monostearate
Ramiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Ramiprilat.
Aluminium monostearate
Fosinoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Fosinoprilat.
Aluminium monostearate
Benazeprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Benazeprilat.
Aluminium monostearate
Delapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Delapril.
Aluminium monostearate
Zofenopril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Zofenopril.
Aluminium monostearate
Imidapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Imidapril.
Aluminium monostearate
Enalaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexibuprofen is combined with Enalaprilat.
Aluminium monostearate
Candesartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Dexibuprofen.
Aluminium monostearate
Fimasartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Dexibuprofen.
Aluminium monostearate
Azilsartan medoxomil
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Dexibuprofen.
Aluminium monostearate
Saralasin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Dexibuprofen.
Aluminium monostearate
Tenofovir
Dexibuprofen may increase the nephrotoxic activities of Tenofovir.
Aluminium monostearate
Tenofovir alafenamide
Dexibuprofen may increase the nephrotoxic activities of Tenofovir alafenamide.